Screening for Coronary Artery Disease in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
R Velusamy, M Nolan, A Murphy, P Thavendiranathan… - Cardio Oncology, 2023 - jacc.org
Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in
cancer survivors. This review identifies features that could help guide decisions about the …
cancer survivors. This review identifies features that could help guide decisions about the …
Genomic aging, clonal hematopoiesis, and cardiovascular disease
P Natarajan - Arteriosclerosis, thrombosis, and vascular biology, 2023 - Am Heart Assoc
Chronologic age is the dominant risk factor for coronary artery disease but the features of
aging promoting coronary artery disease are poorly understood. Advances in human …
aging promoting coronary artery disease are poorly understood. Advances in human …
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
FN Salloum, CG Tocchetti, P Ameri, H Ardehali… - Cardio Oncology, 2023 - jacc.org
Despite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has
risen to become a prominent clinical challenge. This has led to the growth of the burgeoning …
risen to become a prominent clinical challenge. This has led to the growth of the burgeoning …
Cardiovascular disease and cancer: shared risk factors and mechanisms
Cardiovascular disease (CVD) and cancer are among the leading causes of morbidity and
mortality globally, and these conditions are increasingly recognized to be fundamentally …
mortality globally, and these conditions are increasingly recognized to be fundamentally …
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute …
D Backhaus, D Brauer, R Pointner, L Bischof… - Bone Marrow …, 2023 - nature.com
For most acute myeloid leukemia (AML) patients an allogeneic hematopoietic stem cell
transplantation (HSCT) offers the highest chance of cure. The introduction of less toxic non …
transplantation (HSCT) offers the highest chance of cure. The introduction of less toxic non …
Bidirectional relationship between cancer and heart failure: insights on circulating biomarkers
Cancer and heart failure are the two leading causes of death in developed countries. These
two apparently distinct clinical entities share similar risk factors, symptoms, and …
two apparently distinct clinical entities share similar risk factors, symptoms, and …
Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues
R Bhatnagar, NM Dixit, EH Yang… - Frontiers in …, 2022 - frontiersin.org
Atherosclerotic cardiovascular disease is a growing threat among cancer patients. Not
surprisingly, cancer-targeting therapies have been linked to metabolic dysregulation …
surprisingly, cancer-targeting therapies have been linked to metabolic dysregulation …
Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges
M Olivi, F Di Biase, G Lanzarone, G Arrigo… - … Treatment Options in …, 2023 - Springer
Opinion statement Prophylaxis and treatment of thrombosis in leukemic patients still
represent a major challenge with several clinical questions yet to be solved. Indeed, the …
represent a major challenge with several clinical questions yet to be solved. Indeed, the …
Social Determinants of Health in Cardio-Oncology: Multi-Level Strategies to Overcome Disparities in Care: JACC: CardioOncology State-of-the-Art Review
F Osei Baah, S Sharda, K Davidow, S Jackson… - Cardio Oncology, 2024 - jacc.org
Addressing the need for more equitable cardio-oncology care requires attention to existing
disparities in cardio-oncologic disease prevention and outcomes. This is particularly …
disparities in cardio-oncologic disease prevention and outcomes. This is particularly …
Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models
Y Pan, C Wang, WX Zhou, Y Shi, XD Meng… - Science Translational …, 2024 - science.org
Clinical treatment of acute myeloid leukemia (AML) largely relies on intensive
chemotherapy. However, the application of chemotherapy is often hindered by cardiotoxicity …
chemotherapy. However, the application of chemotherapy is often hindered by cardiotoxicity …